Medical Disorders
Basic InformationLookupsLatest News
What Was More Deadly for New Yorkers – COVID-19 or the 1918 Flu?U.S. Coronavirus Death Tally Hits New High for SummerPfizer's COVID Vaccine Shows 'Robust' Results in Early TrialFrequent COVID Tests Key to College Reopening: ExpertsMany Community Outbreaks of COVID Traced to Restaurants, BarsPut the Brakes on Driving After a ConcussionStrict, Costly Measures Needed to Reopen Schools: StudyCOVID-19 Risk Up to 7 Times Higher for Young VapersAnother COVID Hazard: False InformationHospitals Full, Doctors Treated Her Severe COVID-19 at HomeFDA Approves First Oral Drug for Spinal Muscular AtrophyCOVID-19 Fears Stop Americans From Seeking Help for Heart EmergenciesAHA News: What Do Heart Patients Need to Know About COVID-19 Now?Have Diabetes? Don't Lose Sight of Danger to Your EyesBlood Test Might Spot Most Dangerous COVID-19 CasesAs Schools Reopen, Report Shows 97,000 U.S. Kids Infected With COVID in Late JulyWhat Parents Need to Know About Teens and ConcussionsBaby's Meningitis Case Highlights Growing Danger of Antibiotic ResistanceAs in Adults, Minority Kids Hit Hardest by COVID-19Simple Test Shows Which Face Masks Are BestBeware of Hand Sanitizers Containing MethanolWhat Athletes Should Know About COVID-19, Heart Damage and Working OutCOVID-19 Causing More Stress in America Than Other Nations: SurveyWill Your Kid Play School Sports This Fall? Here's Some Guidance on Doing It SafelyScientists Call for Broader Use of Faster COVID TestsPeople Are Dying, Going Blind After Drinking Hand Sanitizer, CDC WarnsMore Social Media Use, More Fake COVID NewsSkip the 'Maskne,' Not the MaskObesity Ups Odds for Severe COVID-19, But Age MattersSeven States Join Pact to Speed Coronavirus TestingStudy Casts Doubt on Value of Cholesterol DrugsCOVID-19 Fears Had Sick, Injured Americans Avoiding ERsCancer Diagnoses Plunge as Americans Avoid Screening During PandemicMysterious Paralyzing Illness in Kids Is Set to Return, CDC WarnsMany Older Americans Staying Strong in the PandemicCoronavirus Cases Now Climbing in the MidwestCould the First Drug That Slows Arthritis Be Here?Schools Can Reopen Safely If Precautions in Place, Australian Study ShowsFace Masks, Yes, But Don't Forget Hand-Washing TooEven With PPE, Risk of COVID-19 Still High for Frontline WorkersCoronavirus Pandemic Becoming Far More Widespread, Birx SaysGuard Against Lyme Disease This SummerKids 'Efficient' Transmitters as COVID-19 Raced Through a Georgia Summer CampCollege Students Will Need COVID Tests Every 2-3 Days for Campus Safety: StudyAHA News: Sustained High Blood Pressure May Damage Brain VesselsAnother Side Effect of COVID-19 -- Lasting Hearing Problems?Pandemic Could Complicate Hurricane SeasonStudy Reveals How Coronavirus Travels IndoorsNew Study Sheds Doubt on Notion Kids Aren't COVID-19 SpreadersAHA News: Are Virtual Doctor Visits Safe for Discharged Heart Failure Patients?
Questions and AnswersVideosLinksBook Reviews
Related Topics

Men's Health
Women's Health

Antibodies Fade a Few Weeks After Mild COVID-19, Study Finds

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Jul 22nd 2020

new article illustration

WEDNESDAY, July 22, 2020 (HealthDay News) -- Hopes for robust, long-term antibody protection after a bout of COVID-19 have been dampened by a new study that finds the protection may only last a few months.

Still, experts noted that the body's immune system has more than one way to defend against viruses it has already encountered, so the findings don't dash hopes for a vaccine.

"Infection with this coronavirus does not necessarily generate lifetime immunity," Dr. Buddy Creech, an infectious disease specialist at Vanderbilt University in Nashville, told the Associated Press.

But antibodies are only part of the immune system's armamentarium, added Creech, who wasn't part of the new research.

The study was published July 21 in the New England Journal of Medicine. Researchers led by Dr. Otto Yang, of the University of California, Los Angeles, sought to determine the "half-life" of antibodies generated by contact with the new SARS-CoV-2 virus. Half-life means the time it takes for half of the antibodies to disappear.

Yang's group took blood samples from 34 people who had all recovered from a mild case of COVID-19. Twenty were women and 14 were men, and they averaged 43 years of age.

Based on blood tests collected up to 119 days after the onset of symptoms, the researchers said the half-life of antibodies linked with SARS-CoV-2 infection was just 36 days -- just over a month. At that rate, antibodies would disappear completely in about a year.

It's an "antibody loss [rate] that was quicker than that reported for SARS-CoV-1," the coronavirus responsible for the 2003 SARS outbreak, the researchers noted.

"Our findings raise concern that humoral [found in body fluids] immunity against SARS-CoV-2 may not be long lasting in persons with mild illness, who compose the majority of people with COVID-19," they said.

"Like the common cold-causing coronaviruses, the new coronavirus does not appear to provide durable antibody-based immunity for a long period of time," said Dr. Amesh Adalja, a senior scholar with the Johns Hopkins Center for Health Security in Baltimore.

But that doesn't mean that immunity necessarily is gone, he added, since the human immune system has other tricks up its sleeve.

"It still remains to be seen whether these individuals can be reinfected and, if so, what that clinical course is like, as T-cell immunity is also an important factor to consider," said Adalja, who wasn't involved in the new study.

T-cells are a distinct component of what's known as the adaptive immune system. They help fight infection in many ways, including directly killing infected cells.

For his part, Creech agreed that just because antibodies to SARS-CoV-2 have a relatively short half-life doesn't mean people lose the ability to fight off recurrent infection.

He explained to the AP that antibodies are proteins produced by immune system B cells to help recognize and destroy cells infected with a virus. When a new virus is first encountered, more generalized forms of antibodies are quickly produced, but their specificity against the virus gets increasingly precise as time goes on.

The B cells also develop a kind of memory as to how to generate these precise antibodies if the virus appears in the body again.

"They would get called into action very quickly when there's a new exposure to the virus. It's as if they lie dormant, just waiting," Creech said. T-cells also lie in wait, able to mount a separate battle against infected cells, he said.

And what about hopes for a vaccine?

Efforts to find an effective vaccine are still valid, Creech said, because a vaccine's highly targeted approach against viruses actually exceeds that of the natural immune system.

"This shouldn't dissuade us from pursuing a vaccine," Creech said. "Antibodies are only a part of the story."

More information

For more on how the immune system works, see the U.S. Library of Medicine.


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net